Ischemic heart disease Board decisions

The veteran's claims for earlier effective dates for service connection and increased ratings were denied. However, the veteran was granted an initial 60 percent rating from September 12, 2018 to May 17, 2020, and a 100 percent rating from November 2, 2020 for coronary artery disease, as well as an effective date of September 12, 2018 for special monthly compensation at the housebound rate.

The Veteran's daughter was granted special monthly compensation based on the need for regular aid and attendance due to the Veteran's service-connected disabilities.

The Board remanded all issues to the VA for further evaluation and examinations. The Veteran's claims were not granted or denied at this time.

The appeals for service connection of colon cancer, coronary artery disease, diabetes, gall bladder cancer, and pancreatic cancer were dismissed without prejudice due to the veteran's death.

The Board reversed the severance of service connection for coronary artery disease (CAD) due to a clear and unmistakable error (CUE). Service connection for CAD was reinstated effective March 1, 2016.

The Board granted service connection for a heart disorder, diagnosed as atherosclerotic cardiovascular disease, coronary artery disease, and congestive heart failure, status post myocardial infarction, due to the Veteran's participation in toxic exposure risk activity during service.

The Board has remanded the claims for service connection for diabetes mellitus, CAD, and erectile dysfunction due to conflicting TERA memoranda and an inadequate medical opinion.

The Board has remanded the case for additional development, including a VA examination to consider evidence of electrocardiograms prior to 2016 and an article regarding the effects of lightning strike provided by the veteran's representative. The appeal is currently before the Board.

The Board remands the claims for further development, including obtaining outstanding SSA records and a new medical opinion regarding the Veteran's heart condition.

The veteran's claim for service connection for coronary artery disease (CAD) caused by service-connected hypertension was granted. However, the claim for bilateral hearing loss was denied.

The Board denied service connection for coronary artery disease, finding no evidence that it was incurred in service or due to contaminated water at Camp Lejeune.

The veteran's service connection for type II diabetes mellitus and coronary artery disease, due to herbicide agent exposure, is granted.

The Board remanded all issues to the Regional Office for further development of evidence and a new decision.

The appeal was dismissed because the veteran died while it was pending. The dismissal does not affect the right of an eligible person to take the Veteran's place to continue the appeal on the pending claim(s).

The Veteran's claim for service connection for a heart condition was denied. The claims for cervical strain, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and an artery or vein condition were remanded for further development.

The Board denied the veteran's appeal to restore a 60 percent evaluation for ischemic heart disease, confirming that the reduction to 30 percent was proper due to a clear and unmistakable error in the February 2020 rating decision.

The Veteran's appeals for service connection of prostate cancer and coronary artery disease were denied because the requests for Higher-level Review were not filed on time.

The appeal for service connection of heart conditions is remanded due to inadequate medical opinions. The Board needs more information on the relationship between the veteran's heart conditions and his service-connected hypertension, as well as his exposure to herbicide agents.

The appeal for service connection of a heart condition is remanded. The VA needs to provide an adequate medical examination and opinion.

The veteran's claim for service connection for colon cancer was remanded. The veteran was granted an increased rating of 50 percent for unspecified trauma and stressor related disorder, but denied increases for diabetes and upper extremity neuropathy. Increased ratings were granted for lower extremity neuropathy.